JUL 22, 2019 3:35 PM PDT

New Diabetes Gene Revealed by Large Study of African Populations

WRITTEN BY: Carmen Leitch

While we all carry more or less the same genes, tiny differences in the sequences of those genes can have major ramifications. Genome-wide association studies (GWAS) help researchers identify the variations in gene sequences that have an impact on a trait, like a susceptibility to disease. Most GWAS that have been performed have focused on populations with European ancestry while ignoring others, and as such, there is a dearth of information when it comes to some groups, like Africans.  Geneticists are aware of the problem (discussed in the video below) and have been working for some time to expand what we know about the genetics of these underserved populations.

Image credit: Max Pixel

“Africa is the original cradle of all humanity, to which all humans can trace their genetic origin,” said study co-author Francis S. Collins, M.D., Ph.D., a senior investigator with the National Human Genome Research Institute (NHGRI) Medical Genomics and Metabolic Genetics Branch. “Thus, studying the genomes of Africans offers important opportunities to understand genetic variation across all human populations.”

A study recently published in Nature Communications by researchers at the National Institutes of Health and the University of Maryland, Baltimore (full disclosure: I am one of the study authors), is the largest type 2 diabetes (T2D) GWAS study done with a sub-Saharan African population. After assessing data from 5,231 people in Ghana, Nigeria, and Kenya, the team identified variations in several genes that are linked to diabetes. The report focused on one of those genes, called ZRANB3. While the researchers had learned that the gene is connected to diabetes, they want to know more about how.

“In the early days of large-scale genomic studies, we did not know the effect of genes we found through our statistical tests,” explained study first author Dr. Adebowale Adeyemo, NHGRI researcher. “But with the availability of new genomic tools, our next step was to ask: What does ZRANB3 do? How does it confer risk for T2D, and by what mechanisms does it act? That is the knowledge that will help the results become actionable for patients.”

The scientists studied the impact of the ZRANB3 gene in zebrafish. Since zebrafish are transparent, they can be observed throughout development. A transgenic model was used in this study, in which the beta cells in the zebrafish pancreas glow red. The beta cells produce insulin, which is a molecule that helps control the level of glucose in the blood. I created a ZRANB3 knockout in this model using the CRISPR/Cas9 gene-editing system that targeted the ZRANB3 zebrafish gene and we watched the effects.

Confocal microscopy revealed that when ZRANB3 was down-regulated in fish, it reduced the number of beta cells in their pancreas. These results were confirmed in mouse cells growing in culture.

While this study has revealed more about a genetic variation likely to be found in Africans, the variant might also be carried by people in other groups as well. It can also help us understand more about the genetics underlying a complex disorder like diabetes, which is more likely to arise in some people that carry certain genetic variations. We may also be able to one day predict who will probably develop certain diseases based on the genetic variations they have.

“The findings of this study further demonstrate why it is important to study all human populations. By doing so, we have the opportunity to make novel discoveries that will not only help the specific population but also people all around the globe,” said study senior author Dr. Charles Rotimi. “The biology then becomes generalizable, and that much more impactful.”

Learn more about GWAS from the video.

Sources: NHGRI, Nature Communications

About the Author
BS
Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
APR 20, 2022
Cancer
A Specialized Mouse Model Identifies Genetic Regulators of Immunotherapy Response
APR 20, 2022
A Specialized Mouse Model Identifies Genetic Regulators of Immunotherapy Response
Recent advances in immune checkpoint inhibitors (ICI) have led to significant clinical benefits for patients with variou ...
MAY 25, 2022
Cancer
TCGA: An Important Tool for Cancer Research
MAY 25, 2022
TCGA: An Important Tool for Cancer Research
In 2006, the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI) began a cancer gen ...
JUN 16, 2022
Genetics & Genomics
One in 500 Men Carry an Extra Sex Chromosome
JUN 16, 2022
One in 500 Men Carry an Extra Sex Chromosome
Humans carry 46 chromosomes. We get one from each parent, making 22 pairs of autosomal chromosomes, and one pair of sex ...
JUN 25, 2022
Genetics & Genomics
Similar 'Jumping Genes' are Active in Human and Octopus Brains
JUN 25, 2022
Similar 'Jumping Genes' are Active in Human and Octopus Brains
Cephalopods, including octopuses, have exceptionally large and complex nervous systems; the octopod brain is thought to ...
JUN 27, 2022
Cancer
A Genomic Scan Detects Cancer-Driving Mutations
JUN 27, 2022
A Genomic Scan Detects Cancer-Driving Mutations
Cancer develops when the DNA in our cells becomes altered, resulting in a gene mutation.  DNA alterations can occur ...
JUL 21, 2022
Clinical & Molecular DX
Scientists Find a Potential Cause and Treatment for Shorter Life Span in Men
JUL 21, 2022
Scientists Find a Potential Cause and Treatment for Shorter Life Span in Men
Scientists are beginning to understand the significant impact of a process called hematopoietic mosaic loss of Y chromos ...
Loading Comments...